ArrowMark Colorado Holdings’s Core Laboratories CLB Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-50,000	Closed	-$5.79M	–	340
2018 Q3	$5.79M	Sell	50,000 -10,000	-17%	-$1.13M	0.05%	229
2018 Q2	$7.57M	Hold	60,000	–	–	0.07%	211
2018 Q1	$6.49M	Buy	60,000 +8,000	+15%	+$885K	0.06%	214
2017 Q4	$5.7M	Buy	+52,000	New	+$5.19M	0.06%	212
2016 Q1	–	Sell	-290,055	Closed	-$31.5M	–	262
2015 Q4	$31.5M	Sell	290,055 -75,532	-21%	-$8.65M	0.86%	36
2015 Q3	$36.5M	Buy	365,587 +66,413	+22%	+$7.22M	1%	29
2015 Q2	$34.1M	Sell	299,174 -3,740	-1%	-$454K	0.83%	42
2015 Q1	$31.7M	Buy	302,914 +177,373	+141%	+$18.9M	0.82%	43
2014 Q4	$15.1M	Buy	125,541 +49,357	+65%	+$6.48M	0.39%	79
2014 Q3	$11.2M	Buy	76,184 +13,260	+21%	+$2.05M	0.31%	109
2014 Q2	$10.5M	Sell	62,924 -3,984	-6%	-$709K	0.3%	116
2014 Q1	$13.3M	Buy	66,908 +3,194	+5%	+$603K	0.43%	89
2013 Q4	$12.2M	Sell	63,714 -95,286	-60%	-$17.7M	0.38%	102
2013 Q3	$26.9M	Buy	+159,000	New	+$24.7M	0.89%	35

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

ArrowMark Colorado Holdings's CLB Position: Q4 2018 in Review

ArrowMark Colorado Holdings sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 50,000 shares — an estimated $5.79M sold.

ArrowMark Colorado Holdings first reported a position in CLB in Q3 2013 and held it in 14 quarters. The position peaked at $36.5M in Q3 2015. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.

ArrowMark Colorado Holdings reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
ArrowMark Colorado Holdings sold 50,000 Core Laboratories shares in Q4 2018, an estimated $5.79M.
ArrowMark Colorado Holdings first reported a position in Core Laboratories in Q3 2013 and held it in 14 quarters.
ArrowMark Colorado Holdings's Core Laboratories position peaked at $36.5M in Q3 2015.
320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.